NCI vs FCN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

NCI

37.6
AI Score
VS
NCI Wins

FCN

32.2
AI Score

Investment Advisor Scores

NCI

38score
Recommendation
AVOID NEW MONEY

FCN

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI FCN Winner
Forward P/E 0 18.9036 Tie
PEG Ratio 1.13 0.9597 FCN
Revenue Growth -7.4% 5.9% FCN
Earnings Growth 34.0% -9.6% NCI
Tradestie Score 37.6/100 32.2/100 NCI
Profit Margin -8.1% 5.9% FCN
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED FCN

Relative Price Performance (Last 90 Days)

NCI 1M: +642.4% · 3M: -58.1% FCN 1M: +41.8% · 3M: +30.8%

Current Technical Phase

NCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.4 · Price: $5.12

FCN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.5% over 20 days), RSI 81

RSI (14): 80.8 · Price: $198.62

Fundamentals Snapshot

Metric NCI FCN
Market Cap — —
Forward P/E 0.0 17.8
Trailing P/E — 24.6
Revenue (TTM) — —
Revenue Growth -0.5% 0.1%
Gross Margin 0.4% 0.3%
Operating Margin 0.0% 0.1%
EPS -8.26 8.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.